Health

Ionis Wins FDA Approval for Alexander Disease Drug

Updated 2026-09-03 20:55 UTC 1 source Positive

Ionis Pharmaceuticals has won FDA approval for Zanvastro, the first disease-modifying treatment for Alexander disease. This rare and fatal neurological disorder affects thousands of patients globally.

Coverage timeline — 1 article
STAT News
Zanvastro is the first disease-modifying treatment for Alexander disease, a rare and fatal disorder.
2026-09-03 20:45 UTC
Share: Twitter / X LinkedIn